Aviwell Raises €11M Series A Funding to Scale Microbiome-Based Animal Health Platform

Biotech Startup Secures Series A Funding to Advance Livestock Nutrition Innovation

Aviwell, a biotech and animal health company, has raised €11 million in Series A funding to expand its microbiome-based nutrition platform for livestock. The round was backed by growth-stage venture investors focused on agri-tech, animal health innovation, and biotech solutions. The funding will support research and development, product commercialization, and scaling operations to meet growing demand for sustainable and science-driven livestock nutrition.

Founded in 2022, Aviwell develops precision nutrition solutions that optimize animal gut health, growth performance, and disease resistance through microbiome modulation. Its platform leverages advanced data analytics and microbiome science to create customized feed interventions, helping farmers improve productivity while reducing disease risk and environmental impact.

Improving Animal Health and Livestock Productivity

The livestock industry faces increasing challenges from disease outbreaks, antibiotic resistance, and sustainability pressures. Aviwell’s microbiome-based interventions are designed to enhance feed efficiency, promote healthier growth, and support overall animal welfare. By analyzing gut microbial composition, Aviwell creates personalized nutrition strategies for cattle, swine, and poultry that optimize nutrient absorption and strengthen immunity.

Aviwell’s approach combines cutting-edge microbiome science with practical farming applications, allowing producers to adopt evidence-based solutions that improve operational efficiency. These data-driven interventions help livestock producers reduce reliance on antibiotics and other traditional treatments, aligning with growing consumer and regulatory demands for sustainable, high-quality meat and dairy products.

Deployment of Series A Funding

The €11 million Series A funding will be used to:

1. Scale research and development of microbiome-based nutrition products
2. Expand manufacturing and distribution capabilities to reach new markets
3. Conduct clinical trials to validate product efficacy across livestock species
4. Strengthen sales and technical support teams to assist farmers with implementation

Investors recognize Aviwell’s potential to redefine livestock nutrition through microbiome-based solutions, helping to drive efficiency, sustainability, and profitability in animal agriculture.

Market Context and Competitors

The global animal health market is projected to reach $60 billion by 2028, driven by increasing demand for meat, sustainability initiatives, and innovation in feed and nutrition solutions. Aviwell competes with traditional feed supplement providers and emerging biotech startups focusing on gut health, probiotics, and microbiome modulation.

By integrating AI-driven analytics with microbiome research, Aviwell differentiates itself through precision nutrition strategies that are scalable, adaptable, and grounded in science. This approach positions the company as a leader in the emerging sector of data-driven livestock health solutions.

Future Plans and Industry Impact

Looking ahead, Aviwell plans to launch next-generation products in Europe and North America, targeting poultry, swine, and cattle markets. The company also aims to expand scientific collaborations and explore partnerships with feed and agri-tech companies to accelerate adoption.

Sustainability remains a key focus. By improving feed efficiency and animal health, Aviwell’s solutions have the potential to reduce greenhouse gas emissions, lower feed waste, and support sustainable livestock production. These innovations align with broader industry trends toward environmentally responsible farming and regulatory compliance.

The startup is also committed to educational outreach, helping farmers, agribusiness partners, and industry stakeholders understand the benefits of microbiome-based nutrition and the role of science-driven livestock health solutions. By combining cutting-edge biotech research with market-focused strategies, Aviwell is positioned to drive a global shift in precision animal nutrition, contributing to healthier livestock, more efficient farming, and sustainable food systems worldwide.

In addition, the company plans to collaborate with universities, research institutes, and regulatory bodies to advance the science of livestock microbiome management, ensure compliance with evolving standards, and accelerate adoption of its solutions across diverse agricultural markets. These efforts aim to create a robust ecosystem where innovation, sustainability, and profitability go hand in hand, reinforcing Aviwell’s vision as a leader in next-generation animal health technologies.